These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36743186)

  • 1. Predictors of health state utility values using SF-6D for Chinese adult patients with β-thalassemia major.
    Zhang R; Zhang S; Ming J; Xie J; Liu B; Chen C; Sun X; Zhen X
    Front Public Health; 2022; 10():1072866. PubMed ID: 36743186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying SF-6D to measure health state utilities among the middle and old aged patients with hypertension in China.
    Liu X; Bai G; Li H; Li S
    Health Qual Life Outcomes; 2020 Dec; 18(1):385. PubMed ID: 33308242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire.
    Haghpanah S; Nasirabadi S; Ghaffarpasand F; Karami R; Mahmoodi M; Parand S; Karimi M
    Sao Paulo Med J; 2013; 131(3):166-72. PubMed ID: 23903265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility estimations of health states of older Australian women with atrial fibrillation using SF-6D.
    Abbas SS; Majeed T; Weaver N; Nair BR; Forder PM; Byles JE
    Qual Life Res; 2021 May; 30(5):1457-1466. PubMed ID: 33550542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study: caregiver burden and related determinants of adult patients with β-thalassemia major in mainland China.
    Zhang R; Zhang S; Ming J; Xie J; Liu B; Jiang W; Fu Y; Zhen X; Sun X
    BMC Nurs; 2024 Mar; 23(1):151. PubMed ID: 38439062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SF-6D population norms for the Hong Kong Chinese general population.
    Wong CKH; Mulhern B; Cheng GHL; Lam CLK
    Qual Life Res; 2018 Sep; 27(9):2349-2359. PubMed ID: 29797176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China.
    Yang Q; Jiang LL; Li YF; Huang D
    Health Qual Life Outcomes; 2023 Nov; 21(1):122. PubMed ID: 37964348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors.
    Hosseini K; Omorou AY; Hubert J; Ngueyon Sime W; Ladrière M; Guillemin F
    Value Health; 2017 Dec; 20(10):1376-1382. PubMed ID: 29241897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health state utility instruments compared: inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D.
    Gamst-Klaussen T; Chen G; Lamu AN; Olsen JA
    Qual Life Res; 2016 Jul; 25(7):1667-78. PubMed ID: 26687615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are English- and Chinese-language versions of the SF-6D equivalent? A comparison from a population-based study.
    Wee HL; Cheung YB; Fong KY; Luo N; Machin D; Thumboo J
    Clin Ther; 2004 Jul; 26(7):1137-48. PubMed ID: 15336479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.
    Haghpanah S; Vahdati S; Karimi M
    Hemoglobin; 2017 May; 41(3):169-174. PubMed ID: 28741988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life and Depression in Turkish Patients with β-Thalassemia Major: A Cross-Sectional Study.
    Töret E; Karadaş NÖ; Gökçe NÖ; Kaygusuz A; Karapınar TH; Oymak Y; Gözmen S
    Hemoglobin; 2018; 42(5-6):326-329. PubMed ID: 30672351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher diet quality is associated with short and long-term benefits on SF-6D health state utilities: a 5-year cohort study in an international sample of people with multiple sclerosis.
    Kirkland H; Campbell J; Reece J; Nag N; Probst Y; Neate S; De Livera A; Jelinek G; Simpson-Yap S
    Qual Life Res; 2023 Jul; 32(7):1883-1896. PubMed ID: 36821020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis.
    Campbell JA; Jelinek GA; Weiland TJ; Nag N; Neate SL; Palmer AJ; Mulhern B; De Livera A; Simpson-Yap S
    Qual Life Res; 2020 Sep; 29(9):2509-2527. PubMed ID: 32488685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of heart failure and health-related quality of life in beta-thalassemia patients: a cross-sectional study.
    Dimitroglou Y; Anagnostopoulos F; Aggeli C; Delicou S; Xydaki A; Patsourakos D; Tousoulis D
    Ann Hematol; 2020 Sep; 99(9):2037-2046. PubMed ID: 32436014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians.
    Singh A; Campbell JA; Venn A; Jones G; Blizzard L; Palmer AJ; Dwyer T; Cicuttini F; Ding C; Antony B
    Qual Life Res; 2021 Sep; 30(9):2601-2613. PubMed ID: 33942204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy.
    Flint I; Medjedovic J; Drogon O'Flaherty E; Alvarez-Baron E; Thangavelu K; Savic N; Meunier A; Longworth L
    Eur J Health Econ; 2023 Sep; 24(7):1061-1072. PubMed ID: 36260149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.